Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Hepalink Group logo — Discover, develop, and commercialize high-quality, safe and...

Hepalink Group

Discover, develop, and commercialize high-quality, safe and effective medicines and services to address patients’ unmet

Founded 1998 China Shenzhen, China 108 employees Pharmaceutical

General Information

Company Name Hepalink Group
Founded Year 1998
Location China Shenzhen, China
Employees 108
Industries Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Hepalink Group. To contact Hepalink Group, visit hepalink.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hepalink Group compare?

A PDF of Hepalink Group and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hepalink Group soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hepalink Group

Hepalink Group is a multinational biopharmaceutical company that was established in 1998 in Shenzhen, China. The company is dual-listed in Hong Kong and mainland China. Its core business is centered around the heparin industrial chain, large molecule biologics CDMO services, and the research, development, and commercialization of innovative drugs. The company's slogan reflects its commitment to discovering, developing, and commercializing high-quality, safe, and effective medicines and services to address patients’ unmet medical needs. Hepalink operates in three synergistic business segments, all of which are dedicated to addressing patients’ unmet medical needs and bringing safe and effective therapies and services to patients around the world. Despite lacking specific information regarding the last investment and the last investment investors, the company's track record and focus on the pharmaceutical industry in China indicate strong growth potential and a commitment to addressing critical healthcare challenges. Overall, Hepalink Group's positioning in the pharmaceutical industry and its dedication to addressing unmet medical needs could make it an attractive investment opportunity for venture capitalists seeking exposure to the rapidly evolving healthcare landscape in China and beyond.

Business keywords: biopharmaceutical, heparin, CDMO services, innovative drugs, multinational, pharmaceutical, biologics, commercialization, Shenzhen, China, publicly listed, medical needs, pharmaceutical industry, biopharmaceutical company

No funding data available for Hepalink Group yet.

Hepalink Group Alternatives & Competitors

View All Alternatives
Hepalink Group vs
Basilea Pharmaceutica
Basilea Pharmaceutica Switzerland

For the benefit of patients

Grant
215 employees
Biotechnology, Pharmaceutical
Hepalink Group vs
Reistone Biopharma
Reistone Biopharma China

Focusing on rapidly developing innovative medicines through global collaborations within Research an...

Series A
52 employees
Biotechnology, Pharmaceutical
Hepalink Group vs
Intellective Bio
Intellective Bio China

Your Trusted Development & Manufacturing Partner

Series C
5 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Hepalink Group

Discover, develop, and commercialize high-quality, safe and effective medicines and services to address patients’ unmet
Hepalink Group was founded in 1998.
Hepalink Group is headquartered in Shenzhen, China.
Hepalink Group operates in Pharmaceutical. Its work centres on biopharmaceutical, heparin, CDMO services and innovative drugs.
Hepalink Group has approximately 108 employees.
Top alternatives and competitors to Hepalink Group include Basilea Pharmaceutica, Reistone Biopharma, Intellective Bio, Theratechnologies Inc., Hasten Biopharmaceutical Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hepalink Group and Basilea Pharmaceutica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hepalink Group, https://bouncewatch.com/company/hepalink-group, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes